İlhan Hacıbekiroğlu

Author

İlhan Hacıbekiroğlu

Also Known As

Hacıbekiroğlu, İlhan, I Hacıbekiroglu, I Hacıbekiroğlu, I. Hacibekiroglu, I. Hacıbekiroglu, ILHAN HACIBEKIROGLU, Ilhan Hacibekiroglu, Ilhan Hacibekıroglu, Ilhan Hacıbekiroglu, Ilhan Hacıbekiroğlu

123

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Sakarya University Trakya University Erciyes University Marmara University Ankara Onkoloji Eğitim ve Araştırma Hastanesi

İH

About

İlhan Hacıbekiroğlu is an author at Sakarya University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	603
2	Pathology	3	3	72
3	Health Sciences	2	2	546
4	Cell Biology	1	1	28
5	Gastroenterology	1	1	25

İlhan Hacıbekiroğlu

Publications

848

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial Sun Young Rha, Do‐Youn Oh, Patricio Yañez, The Lancet Oncology Chemotherapy Versus PlaceboGastrointestinal OncologyMedicineClinical TrialsImmune Checkpoint Inhibitor	2023	521
Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study Ayşe İrem Yasin, Sabin Göktaş Aydın, Bilge Sümbül, Future Oncology	2022	31
K-RAS and N-RAS mutations in testicular germ cell tumors Muhammet Bekir Hacıoğlu, Hilmi Kodaz, Bülent Erdoğan, Bosnian Journal of Basic Medical Sciences Ras Gene MutationsKirsten RasN-ras MutationsGerm CellOncogenic Agent	2017	28
Clinicopathological Characteristics and Prognosis of Patients According to Recurrence Time After Curative Resection for Colorectal Cancer Oktay Bozkurt, Mevlüde İnanç, Esma Türkmen, Asian Pacific Journal of Cancer Prevention	2014	25
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors Hilmi Kodaz, İlhan Hacıbekiroğlu, Bülent Erdoğan, Molecular and Clinical Oncology GastroenterologyPathologyTumor BiologyOncologyClinicopathological Characteristics	2014	25
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy Cengiz Karaçin, Berna Öksüzoğlu, Ayşe Demirci, BMC Cancer	2023	23
Efficacy of Metronomic Vinorelbine in Elderly Patients with Advanced Non-Small-Cell Lung Cancer and Poor Performance Status Cemil Bilir, Serdar Durak, Bayram Kızılkaya, Current Oncology	2017	22
Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients? Oktay Bozkurt, Halıt Karaca, İlhan Hacıbekiroğlu, Journal of Chemotherapy	2015	21
Relationship between serum osteopontin levels and the severity of COVID-19 infection Ceyhun Varım, Taner Demirci, Hasret Cengiz, Wiener klinische Wochenschrift	2020	21
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer Seda Kahraman, Enes Erul, Mustafa Seyyar, Future Oncology	2023	21

Page 1